{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T15:08:06Z","timestamp":1696950486657},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1007\/bf03351061","type":"journal-article","created":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T08:33:39Z","timestamp":1398846819000},"page":"353-356","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel\/ethinyl estradiol combination"],"prefix":"10.1007","volume":"27","author":[{"given":"M.","family":"Bahceci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bilge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tuzcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tuzcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bahceci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,29]]},"reference":[{"key":"BF03351061_CR1","first-page":"3078","volume":"83","author":"ES Knochenhauer","year":"1998","unstructured":"Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998, 83: 3078\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03351061_CR2","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961, 21: 1440\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03351061_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03343536","volume":"22","author":"II Muderris","year":"1999","unstructured":"Muderris II, Bayram F. Clinical efficacy of lower dose flutamide 125 mg\/day in the treatment of hirsutism. J Endocrinol Invest 1999, 22: 165\u20138.","journal-title":"J Endocrinol Invest"},{"key":"BF03351061_CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00128071-200001020-00003","volume":"1","author":"L Falsetti","year":"2000","unstructured":"Falsetti L, Gambera A, Platto C, Legrenzi L. Management of hirsutism. Am J Clin Dermatol 2000, 1: 89\u201399.","journal-title":"Am J Clin Dermatol"},{"key":"BF03351061_CR5","first-page":"81","volume":"85","author":"C Negri","year":"2000","unstructured":"Negri C, Tosi F, Dorizzi R, et al. Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women. J Clin Endocrinol Metab 2000, 85: 81\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03351061_CR6","first-page":"209","volume":"151","author":"H Yu","year":"1999","unstructured":"Yu H, Berkel H. Prostate-specific antigen (PSA) in women. J La State Med Soc 1999, 151: 209\u201313.","journal-title":"J La State Med Soc"},{"key":"BF03351061_CR7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/jcem.82.3.3792","volume":"82","author":"DN Melegos","year":"1997","unstructured":"Melegos DN, Yu H, Ashok M, Wang C, Stanczyk F, Diamandis EP. Prostate-specific antigen in female serum, a potential new marker of androgen excess. J Clin Endocrinol Metab 1997, 82: 777\u201380.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03351061_CR8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0094-0143(05)70373-6","volume":"24","author":"EP Diamandis","year":"1997","unstructured":"Diamandis EP, Yu H. Nonprostatic sources of prostatespecific antigen. Urol Clin North Am 1997, 24: 275\u201382.","journal-title":"Urol Clin North Am"},{"key":"BF03351061_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/oxfordjournals.humrep.a019031","volume":"11","author":"R Homburg","year":"1996","unstructured":"Homburg R. Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod 1996, 11: 29\u201339.","journal-title":"Hum Reprod"},{"key":"BF03351061_CR10","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","volume":"84","author":"A Vermeulen","year":"1999","unstructured":"Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999, 84: 3666\u201372.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03351061_CR11","doi-asserted-by":"crossref","first-page":"RC29","DOI":"10.1007\/BF03345504","volume":"25","author":"L Manetti","year":"2002","unstructured":"Manetti L, Lupi I, Bogazzi F, et al. Prostate-specific antigen is increased in female patients with Cushing\u2019s disease. J Endocrinol Invest 2002, 25: RC29\u201331.","journal-title":"J Endocrinol Invest"},{"key":"BF03351061_CR12","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1210\/jcem.86.4.7378","volume":"86","author":"CV Obiezu","year":"2001","unstructured":"Obiezu CV, Scorilas A, Magklara A, et al. Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001, 86: 1558\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03351061_CR13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0303-7207(86)90132-2","volume":"44","author":"J Simard","year":"1986","unstructured":"Simard J, Luthy I, Guay J, Belanger A, Labrie F. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol 1986, 44: 261\u201370.","journal-title":"Mol Cell Endocrinol"},{"key":"BF03351061_CR14","doi-asserted-by":"crossref","first-page":"104S","DOI":"10.1016\/S0002-9343(99)80067-9","volume":"98","author":"PD Darney","year":"1995","unstructured":"Darney PD. The androgenicity of progestins. Am J Med 1995, 98: 104S\u201310.","journal-title":"Am J Med"},{"key":"BF03351061_CR15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0015-0282(16)57785-1","volume":"64","author":"P Moghetti","year":"1995","unstructured":"Moghetti P, Castello R, Negri C, et al. Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior. Fertil Steril 1995, 64: 511\u20137.","journal-title":"Fertil Steril"},{"key":"BF03351061_CR16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2265.1995.tb02922.x","volume":"43","author":"S Dodin","year":"1995","unstructured":"Dodin S, Faure N, C\u00e9drin I, et al. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism. Clin Endocrinol (Oxf) 1995, 43: 575\u201382.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03351061_CR17","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0015-0282(16)57174-X","volume":"62","author":"L Ciotta","year":"1994","unstructured":"Ciotta L, Cianci A, Marletta E, Pisana L, Agliano A, Palumbo G. Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovary syndrome. Fertil Steril 1994, 62: 1129\u201335.","journal-title":"Fertil Steril"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03351061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03351061\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03351061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T06:52:24Z","timestamp":1558507944000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03351061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["BF03351061"],"URL":"https:\/\/doi.org\/10.1007\/bf03351061","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}